POSTN and systemic sclerosis: Thus, once confirmed in prospective studies on a larger cohort of SSc patients, periostin expression on uninvolved skin could be proposed as a “prognostic biomarker” able to predict skin progression rate and guide a prompt therapeutic intervention.